{"DataElement":{"publicId":"6276850","version":"1","preferredName":"Anal Cancer AJCC Edition 8 Clinical Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for anal carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"ANAL_AJC8_CLN_N_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6078258","version":"1","preferredName":"Anal Neoplasm Clinical N Category","preferredDefinition":"A benign or malignant neoplasm that affects the anal canal or anal margin.  Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma.  Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"6078251v1.0:2428496v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6078251","version":"1","preferredName":"Anal Neoplasm","preferredDefinition":"A benign or malignant neoplasm that affects the anal canal or anal margin.  Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma.  Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.","longName":"C2877","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Neoplasm","conceptCode":"C2877","definition":"A benign or malignant neoplasm that affects the anal canal or anal margin.  Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma.  Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D30DB2-0929-33D4-E053-F662850A5647","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65D30040-64DF-2728-E053-F662850AD70B","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt.  2/22/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6078384","version":"1","preferredName":"Anal Carcinoma American Joint Committee on Cancer Edition 8 N Category","preferredDefinition":"A finding about one or more characteristics of anal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6078384v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N1c","valueDescription":"Anal Cancer pN1c TNM Finding v8","ValueMeaning":{"publicId":"6078388","version":"1","preferredName":"Anal Cancer pN1c TNM Finding v8","longName":"6078388","preferredDefinition":"Anal cancer with metastasis in external iliac with any N1a nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer pN1c TNM Finding v8","conceptCode":"C133785","definition":"Anal cancer with metastasis in external iliac with any N1a nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D27B9D-969B-3123-E053-F662850ABE18","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D27B9D-96B4-3123-E053-F662850ABE18","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"},{"value":"N1b","valueDescription":"Anal Cancer pN1b TNM Finding v8","ValueMeaning":{"publicId":"6078390","version":"1","preferredName":"Anal Cancer pN1b TNM Finding v8","longName":"6078390","preferredDefinition":"Anal cancer with metastasis in external iliac lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer pN1b TNM Finding v8","conceptCode":"C133784","definition":"Anal cancer with metastasis in external iliac lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D27B9D-96C1-3123-E053-F662850ABE18","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D27B9D-96DA-3123-E053-F662850ABE18","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"},{"value":"N1a","valueDescription":"Anal Cancer pN1a TNM Finding v8","ValueMeaning":{"publicId":"6078392","version":"1","preferredName":"Anal Cancer pN1a TNM Finding v8","longName":"6078392","preferredDefinition":"Anal cancer with metastasis in inguinal, mesorectal, or internal iliac lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer pN1a TNM Finding v8","conceptCode":"C133783","definition":"Anal cancer with metastasis in inguinal, mesorectal, or internal iliac lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D27B9D-96E7-3123-E053-F662850ABE18","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D27B9D-9700-3123-E053-F662850ABE18","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"},{"value":"N1","valueDescription":"Anal Cancer pN1 TNM Finding v8","ValueMeaning":{"publicId":"6078394","version":"1","preferredName":"Anal Cancer pN1 TNM Finding v8","longName":"6078394","preferredDefinition":"Anal cancer with metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer pN1 TNM Finding v8","conceptCode":"C133782","definition":"Anal cancer with metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D27B9D-970D-3123-E053-F662850ABE18","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D27B9D-9726-3123-E053-F662850ABE18","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"},{"value":"N0","valueDescription":"Anal Cancer pN0 TNM Finding v8","ValueMeaning":{"publicId":"6078396","version":"1","preferredName":"Anal Cancer pN0 TNM Finding v8","longName":"6078396","preferredDefinition":"Anal cancer with no metastasis to regional lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer pN0 TNM Finding v8","conceptCode":"C133781","definition":"Anal cancer with no metastasis to regional lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D27B9D-9733-3123-E053-F662850ABE18","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D27B9D-974C-3123-E053-F662850ABE18","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"},{"value":"NX","valueDescription":"Anal Cancer pNX TNM Finding v8","ValueMeaning":{"publicId":"6078398","version":"1","preferredName":"Anal Cancer pNX TNM Finding v8","longName":"6078398","preferredDefinition":"Anal cancer in which the regional lymph nodes cannot be assessed.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer pNX TNM Finding v8","conceptCode":"C133780","definition":"Anal cancer in which the regional lymph nodes cannot be assessed.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D27B9D-9759-3123-E053-F662850ABE18","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65D27B9D-9772-3123-E053-F662850ABE18","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6078383","version":"1","preferredName":"Anal Cancer TNM Finding v8 American Joint Committee on Cancer N Stage Category","preferredDefinition":"A finding about one or more characteristics of anal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system.  N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C133762:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer TNM Finding v8","conceptCode":"C133762","definition":"A finding about one or more characteristics of anal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D4AC6D-3EFE-44AA-E053-F662850A8703","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"65D4AC6D-3F0F-44AA-E053-F662850A8703","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 2/22/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6072202","version":"1","longName":"Anus","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical N category","type":"Preferred Question Text","description":"Clinical N category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6C2EB503-0CCD-3CDB-E053-F662850A40AE","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 5/14/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}